London, May 19, 2026, 15:03 (BST)
- Tate & Lyle was last at 514.5 GBX at 15:00 BST, off 1.25% for the session and far under Ingredion’s possible 615p per share. Google
- Tate & Lyle shares are trading in the midst of a UK takeover process after Ingredion put forward a non-binding 595p per share cash offer. The deal also allows for as much as 20p extra in approved dividends. Investegate
- Tate & Lyle’s full-year numbers are due May 21, giving investors a first look before the next immediate test for the company’s standalone case. Tate & Lyle
Tate & Lyle shares dropped in London on Tuesday, slipping further below the price suggested by a possible bid from Ingredion as traders looked for signs the U.S. firm will firm up its offer. The stock traded at 514.5 GBX at 15:00 BST, down 1.25% on the day. The session started at 521p and shares briefly hit 513p. Google
Ingredion is offering up to 615p a share for Tate & Lyle, with 595p in cash and as much as 20p in dividends, but both sides said there’s no guarantee on a firm deal. That discount is in focus now. Investegate
Tate & Lyle said its board is talking with Ingredion after getting several previous approaches. The London-listed food ingredients firm said Ingredion has until 5:00 p.m. London time June 11 to make a firm offer or walk away under UK takeover rules, unless that deadline is pushed back. Tate & Lyle
The stock’s gain landed as UK mid-caps pushed higher. The FTSE 250 was up 0.81% at 11:13 GMT, Reuters said, as weaker labour-market numbers cooled talk of a near-term Bank of England rate increase. Reuters
Tate & Lyle is still trading below the 595p cash part of the offer and the possible 615p total, even after the stock jumped sharply when news of the talks hit. Traders are still pricing in some risk to the bid. Reuters said on May 14 the shares had surged as much as 55% after the proposal was announced. Reuters
The board will have to look at this level, according to Lucinda Guthrie, head of Mergermarket, who told Reuters last week that going public with the approach could work as a “price discovery mechanism” for a possible deal. Reuters
Ingredion said a potential deal could bring “significant benefits” for customers, consumers, staff, and shareholders. The U.S. company confirmed talks and due diligence on Tate & Lyle, saying it is reviewing the business before making any formal bid. Ingredion also said it could change the deal’s structure. Investegate
Tate & Lyle and Ingredion could join forces as food groups keep cutting sugar and calories. Reuters reported that Tate & Lyle, which sells ingredients to companies like Unilever and Nestle, is in talks with Ingredion over a possible deal. A merger could form a food and beverage ingredients giant worth more than $10 billion. Reuters
Tate & Lyle extended its deal with BioHarvest Sciences on Monday, adding more plant-based sweetener molecules to the partnership that started in 2024. “Technical progress” drove the decision, said chief science and innovation officer Victoria Spadaro-Grant, who also said one sweetener would not solve all unmet market needs. Investing
Takeover talk is still driving the action. Regulatory filings on Tuesday included a run of Form 8.3 and Form 8.5 disclosures. Those are required in UK takeover cases when investors or other players have positions or deals to report. London South East
Ingredion might still back out, cut the value of its deal, or run into issues over price, timing or getting the sign-off. Tate & Lyle is set to report on May 21. Investors will see the latest on demand, costs and how CP Kelco is fitting in, before they weigh up the value of Tate & Lyle without any offer. Tate & Lyle
